May 2023
1. MOOIJ CF, van Trotsenburg ASP
   Response to Soheili-Nezhad et al. re: Exploring the Genetic Link Between Thyroid Dysfunction and Common Psychiatric Disorders: A Specific Hormonal or a General Autoimmune Comorbidity.
   Thyroid. 2023 May 24. doi: 10.1089/thy.2023.0184.
   

   >> Share

   
   
2. GROVE-LAUGESEN D, Ebbehoj E, Watt T, Riis AL, et al
   Effect of vitamin D supplementation on Graves' disease: The DAGMAR trial.
   Thyroid. 2023 May 23. doi: 10.1089/thy.2023.0111.
   

   >> Share

   
   
3. 
   Correction to: Exploring the Genetic Link Between Thyroid Dysfunction and Common Psychiatric Disorders: A Specific Hormonal or a General Autoimmune Comorbidity by Soheili-Nezhad et al. Thyroid 2023;33(2):159-168; doi: 10.1089/thy.2022.0304.
   Thyroid. 2023;33:656.
   

   >> Share

   
   February 2023
4. KOPP PA
   Iodine in the therapy of Graves' disease - A century after Henry S. Plummer.
   Thyroid. 2023 Feb 15. doi: 10.1089/thy.2023.0068.
   

   >> Share

   
   
5. SUGISAWA C, Narumi S, Tanase-Nakao K, Ayako H, et al
   Adult Thyroid Outcomes of Congenital Hypothyroidism.
   Thyroid. 2023 Feb 15. doi: 10.1089/thy.2022.0481.
   

   >> Share

   
   
6. LI CW, Osman R, Menconi F, Hou H, et al
   EFFECTIVE INHIBITION OF THYROID ANTIGEN PRESENTATION USING RETRO-INVERSO PEPTIDES IN EXPERIMENTAL AUTOIMMUNE THYROIDITIS: A PATHWAY TOWARDS IMMUNE THERAPIES OF THYROID AUTOIMMUNITY.
   Thyroid. 2023 Feb 10. doi: 10.1089/thy.2022.0511.
   

   >> Share

   
   January 2023
7. MONTEIRO SS, Monteiro MP, Inocencio G, Borges T, et al
   Successful prenatal management of inherited congenital non-autoimmune hyperthyroidism.
   Thyroid. 2023 Jan 31. doi: 10.1089/thy.2022.0648.
   

   >> Share

   
   
8. YOSHIHARA A, Noh JY, Inoue K, Watanabe N, et al
   Incidence of and Risk Factors for Neonatal Hypothyroidism among Women with Graves' Disease Treated with Antithyroid Drugs until Delivery.
   Thyroid. 2023 Jan 21. doi: 10.1089/thy.2022.0514.
   

   >> Share

   
   
9. LU Y, Wang Y, Wang Y, Wu Y, et al
   M1-like macrophages modulate fibrosis and inflammation of orbital fibroblasts in Graves' orbitopathy: Potential relevance to soluble interleukin-6 receptor.
   Thyroid. 2023 Jan 8. doi: 10.1089/thy.2022.0254.
   

   >> Share

   
   December 2022
10. RAO M, Zeng Z, Zhang Q, Su C, et al
    Thyroid autoimmunity is not associated with embryo quality or pregnancy outcomes in euthyroid women undergoing assisted reproductive technology in China.
    Thyroid. 2022 Dec 26. doi: 10.1089/thy.2022.0184.
    

    >> Share

    
    
11. UCHIDA T, Shimamura M, Taka H, Kaga N, et al
    The effect of long-term inorganic iodine on intrathyroidal iodothyronine content and gene expression in mice with Graves' hyperthyroidism.
    Thyroid. 2022 Dec 23. doi: 10.1089/thy.2022.0496.
    

    >> Share

    
    
12. DAVIES TF
    Thyroid Eye Disease: A New Name, A New Guide, and A New Era.
    Thyroid. 2022 Dec 8. doi: 10.1089/thy.2022.0628.
    

    >> Share

    
    
13. BURCH HB, Perros P, Bednarczuk T, Cooper DS, et al
    Management of Thyroid Eye Disease: A Consensus Statement by the American Thyroid Association and the European Thyroid Association.
    Thyroid. 2022 Dec 8. doi: 10.1089/thy.2022.0251.
    

    >> Share

    
    
14. WIERSINGA WM
    Worldwide Consensus on Thyroid Eye Disease? What Is In a Name?
    Thyroid. 2022 Dec 8. doi: 10.1089/thy.2022.29143.
    

    >> Share

    
    
15. SOHEILI-NEZHAD S, Sprooten E, Tendolkar I, Medici M, et al
    Exploring the Genetic Link Between Thyroid Dysfunction and Common Psychiatric Disorders: A Specific Hormonal, or a General Autoimmune Comorbidity.
    Thyroid. 2022 Dec 4. doi: 10.1089/thy.2022.0304.
    

    >> Share

    
    November 2022
16. SEIB CD, Meng T, Cisco RM, Lin DT, et al
    Risk of permanent hypoparathyroidism requiring calcitriol therapy in a population-based cohort of adults older than 65 undergoing total thyroidectomy for Graves' disease.
    Thyroid. 2022 Nov 23. doi: 10.1089/thy.2022.0140.
    

    >> Share

    
    
17. MERAKCHI K, Djerbib S, Dumont JE, Miot F, et al
    Severe autoimmune thyroiditis in transgenic NOD.H2(h4) mice expressing interleukin-4 in the thyroid.
    Thyroid. 2022 Nov 23. doi: 10.1089/thy.2022.0448.
    

    >> Share

    
    
18. CASANY-FERNANDEZ R, Gascon-Gimenez F, Matarredona Solaz EJ, Pardo Lozano F, et al
    REMISSION OF GRAVES DISEASE AFTER INITIATION OF OCRELIZUMAB IN PATIENTS WITH MULTIPLE SCLEROSIS.
    Thyroid. 2022 Nov 23. doi: 10.1089/thy.2022.0398.
    

    >> Share

    
    
19. FENNEMAN AC, Bruinstroop E, Nieuwdorp M, van der Spek AH, et al
    A comprehensive review of thyroid hormone metabolism in the gut and its clinical implications.
    Thyroid. 2022 Nov 2. doi: 10.1089/thy.2022.0491.
    

    >> Share

    
    October 2022
20. HALADA S, Baran J, Isaza A, Patel T, et al
    Impact of Definitive Surgery for Graves' Disease on Adolescent Disease-Specific Quality of Life and Psychosocial Functioning.
    Thyroid. 2022 Oct 17. doi: 10.1089/thy.2022.0334.
    

    >> Share

    
    September 2022
21. AHN HY, Lee J, Lee JK
    Predictive model for Graves' ophthalmopathy in patients with new-onset Graves' disease.
    Thyroid. 2022 Sep 21. doi: 10.1089/thy.2022.0280.
    

    >> Share

    
    
22. HAI Y, Saeed M, Ponto K, Elflein H, et al
    A MULTICENTER, SINGLE-BLIND, CASE-CONTROL, IMMUNOHISTOCHEMICAL STUDY OF ORBITAL TISSUE IN THYROID EYE DISEASE.
    Thyroid. 2022 Sep 21. doi: 10.1089/thy.2022.0173.
    

    >> Share

    
    
23. SUZUKI N, Inoue K, Yoshimura R, Kinoshita A, et al
    The Mediation Role of TRAb in the Relationship between Age and Severity of Hyperthyroidism in Graves' Disease.
    Thyroid. 2022 Sep 8. doi: 10.1089/thy.2022.0252.
    

    >> Share

    
    August 2022
24. KEEFE G, Culbreath K, Cherella CE, Smith JR, et al
    Autoimmune Thyroiditis and Risk of Malignancy in Children with Thyroid Nodules.
    Thyroid. 2022 Aug 11. doi: 10.1089/thy.2022.0241.
    

    >> Share

    
    
25. BRITO JP, Nagy EV, Singh Ospina NM, Zarkovic M, et al
    A survey on the management of thyroid eye disease among American and European Thyroid Association members.
    Thyroid. 2022 Aug 9. doi: 10.1089/thy.2022.0172.
    

    >> Share

    
    July 2022
26. LI L, Chen X, Li B, Liu D, et al
    Effect of Inactivated SARS-CoV-2 Vaccine on Thyroid Function and Autoimmunity within 28 days after the Second Dose.
    Thyroid. 2022 Jul 21. doi: 10.1089/thy.2022.0101.
    

    >> Share

    
    
27. POPPE K
    Are live-birth rates reduced in euthyroid women with thyroid autoimmunity treated with an assisted reproductive technology? The Janus face of a meta-analysis.
    Thyroid. 2022 Jul 12. doi: 10.1089/thy.2022.0370.
    

    >> Share

    
    
28. BUSNELLI A, Beltratti C, Cirillo F, Bulfoni A, et al
    IMPACT OF THYROID AUTOIMMUNITY ON ASSISTED REPRODUCTIVE TECHNOLOGY OUTCOMES AND OVARIAN RESERVE MARKERS: AN UPDATED SYSTEMATIC REVIEW AND META-ANALYSIS.
    Thyroid. 2022 Jul 12. doi: 10.1089/thy.2021.0656.
    

    >> Share

    
    June 2022
29. MCLACHLAN SM, Rapoport B
    Discoveries in Thyroid Autoimmunity in the Past Century.
    Thyroid. 2022 Jun 29. doi: 10.1089/thy.2022.0275.
    

    >> Share

    
    
30. HOU X, Guan H, Sun S, Shi Y, et al
    Outcomes of Early-pregnancy Antithyroid Drug Withdrawal in Graves' Disease: A Preliminary Prospective Follow-up Study.
    Thyroid. 2022 Jun 1. doi: 10.1089/thy.2022.0088.
    

    >> Share

    
    April 2022
31. HUANG Y, Wu Y, Zhang S, Lu Y, et al
    Immunophenotype of lacrimal glands in Graves orbitopathy: Implications for the pathogenesis of Th1 and Th17 immunity.
    Thyroid. 2022 Apr 25. doi: 10.1089/thy.2021.0671.
    

    >> Share

    
    
32. 
    Correction to: Efficacy Profile and Safety of Very Low-Dose Rituximab in Patients with Graves' Orbitopathy by Vannucchi, et al. Thyroid 2021;31(5):821-828; doi: 10.1089/thy.2020.0269.
    Thyroid. 2022 Apr 25. doi: 10.1089/thy.2020.0269.
    

    >> Share

    
    
33. ALVAREZ DE LA SIERRA D, Marin-Sanchez A, Gomez-Brey A, Bello I, et al
    LYMPHOCYTIC THYROIDITIS TRANSCRIPTOMIC PROFILES SUPPORT THE ROLE OF CHECKPOINT PATHWAYS AND B CELLS IN PATHOGENESIS.
    Thyroid. 2022 Apr 10. doi: 10.1089/thy.2021.0694.
    

    >> Share

    
    
34. MORSHED SA, Ma R, Latif R, Davies TF, et al
    Mechanisms in Graves Eye Disease: Apoptosis as the End Point of Insulin-Like Growth Factor 1 Receptor Inhibition.
    Thyroid. 2022;32:429-439.
    

    >> Share

    
    March 2022
35. SUZUKI N, Watanabe N, Noh JY, Yoshimura R, et al
    The relationship between primary thyroid lymphoma and various types of thyroid autoimmunity: A retrospective cohort study of 498 cases, including 9 cases with Graves' disease.
    Thyroid. 2022 Mar 1. doi: 10.1089/thy.2021.0613.
    

    >> Share

    
    February 2022
36. MOSAFERI T, Tsai K, Sovich S, Wilhalme H, et al
    Optimal Thyroid Hormone Replacement Dose in Immune Checkpoint Inhibitor-Associated Hypothyroidism is Distinct from Hashimoto's Thyroiditis.
    Thyroid. 2022 Feb 24. doi: 10.1089/thy.2021.0685.
    

    >> Share

    
    December 2021
37. WOO T, Li C, Ganesananthan S, Rajendram R, et al
    The Effect of Ophthalmic Surgery for Graves' Orbitopathy on Quality of Life - A Systematic Review and Meta-analysis.
    Thyroid. 2021 Dec 8. doi: 10.1089/thy.2021.0411.
    

    >> Share

    
    
38. SUTOH Y, Komaki S, Yamaji T, Suzuki S, et al
    Low MICA gene expression confers an increased risk of Graves' disease: a Mendelian randomization study.
    Thyroid. 2021 Dec 3. doi: 10.1089/thy.2021.0417.
    

    >> Share

    
    November 2021
39. PHILIPP S, Horstmann M, Hose M, Daser A, et al
    An early wave of macrophage infiltration intertwined with antigen specific proinflammatory T-cells and browning of adipose tissue characterizes the onset of orbital inflammation in a mouse model of Graves' orbitopathy.
    Thyroid. 2021 Nov 13. doi: 10.1089/thy.2021.0464.
    

    >> Share

    
    October 2021
40. STAN MN, Algeciras-Schimnich A, Murthy V, Thapa P, et al
    Diagnostic Utility of a New Assay for Thyroid Stimulating Immunoglobulins in Graves' Disease and Thyroid Eye Disease.
    Thyroid. 2021 Oct 29. doi: 10.1089/thy.2021.0299.
    

    >> Share

    
    
41. KRIEGER CC, Kahaly G, Azam A, Klubo-Gwiezdzinska J, et al
    Graves' Autoantibodies Exhibit Different Stimulating Activities in Cultures of Thyrocytes and Orbital Fibroblasts Not Reflected by Clinical Assays.
    Thyroid. 2021 Oct 29. doi: 10.1089/thy.2021.0326.
    

    >> Share

    
    
42. GUNN AH, Frisco N, Thomas S, Stang M, et al
    Patient-Reported Outcomes Following Total Thyroidectomy for Graves' Disease.
    Thyroid. 2021 Oct 19. doi: 10.1089/thy.2021.0285.
    

    >> Share

    
    
43. WANG X, Yang S, Ye H, Chen J, et al
    Disulfiram exerts antiadipogenic, anti-inflammatory, and antifibrotic therapeutic effects in an in vitro model of Graves' orbitopathy.
    Thyroid. 2021 Oct 4. doi: 10.1089/thy.2021.0246.
    

    >> Share

    
    
44. TAPROGGE J, Gape PM, Carnegie-Peake L, Murray I, et al
    A systematic review and meta-analysis of the relationship between the radiation absorbed dose to the thyroid and response in patients treated with radioiodine for Graves' disease.
    Thyroid. 2021 Oct 1. doi: 10.1089/thy.2021.0302.
    

    >> Share

    
    
45. IPPOLITO S, Di Dalmazi G, Pani F, Sabini E, et al
    Distinct cytokine signatures in thyroiditis induced by PD-1 or CTLA-4 blockade: insights from a new mouse model.
    Thyroid. 2021 Oct 1. doi: 10.1089/thy.2021.0165.
    

    >> Share

    
    September 2021
46. HOMMA H, Watanabe M, Inoue N, Isono M, et al
    Polymorphisms in vitamin A-related genes and their functions in autoimmune thyroid disease.
    Thyroid. 2021 Sep 2. doi: 10.1089/thy.2021.0312.
    

    >> Share

    
    August 2021
47. WAN S, Liu L, Ren B, Qu M, et al
    DNA methylation patterns in the HLA-DPB1 and PDCD1LG2 gene regions in patients with autoimmune thyroiditis from different water iodine areas.
    Thyroid. 2021 Aug 12. doi: 10.1089/thy.2021.0221.
    

    >> Share

    
    July 2021
48. PILLI T, Dalmazio G, Porcelli B, Cantara S, et al
    Screening of organ-specific autoantibodies in a large cohort of patients with autoimmune thyroid diseases.
    Thyroid. 2021 Jul 19. doi: 10.1089/thy.2021.0170.
    

    >> Share

    
    
49. OKAZAKI-HADA M, Maruoka A, Yamamoto M, Ito M, et al
    Poorly differentiated thyroid carcinoma coexisting with Graves' disease involving T3 thyrotoxicosis due to increased D1 and D2 activities.
    Thyroid. 2021 Jul 18. doi: 10.1089/thy.2021.0082.
    

    >> Share

    
    
50. CAPPELLANI D, De Marco G, Ferrarini E, Torregrossa L, et al
    Identification of two different phenotypes of patients with amiodarone-induced thyrotoxicosis and positive thyrotropin receptor antibody tests.
    Thyroid. 2021 Jul 16. doi: 10.1089/thy.2021.0118.
    

    >> Share

    
    
51. EKRONARONGCHAI S, Palaga T, Saonanon P, Pruksakorn V, et al
    Histone Deacetylase 4 Controls Extracellular Matrix Production in Orbital Fibroblasts from Graves' Ophthalmopathy Patients.
    Thyroid. 2021 Jul 8. doi: 10.1089/thy.2020.0948.
    

    >> Share

    
    June 2021
52. RYDER M, Wentworth M, Algeciras-Schimnich A, Morris JC 3rd, et al
    Blocking the TSH receptor with K1-70 in a patient with follicular thyroid cancer, Graves' disease and Graves' ophthalmopathy.
    Thyroid. 2021 Jun 11. doi: 10.1089/thy.2021.0053.
    

    >> Share

    
    May 2021
53. KIM J, Choi MS, Park J, Park H, et al
    Changes in Thyroid Stimulating Hormone Receptor Antibody Levels Following Total Thyroidectomy or Radioiodine Therapy in Patients with Refractory Graves' Disease.
    Thyroid. 2021 May 5. doi: 10.1089/thy.2020.0756.
    

    >> Share

    
    April 2021
54. SUZUKI N, Noh JY, Yoshimura R, Mikura K, et al
    Does age or sex relate to severity or treatment prognosis in Graves' disease?
    Thyroid. 2021 Apr 21. doi: 10.1089/thy.2020.0881.
    

    >> Share

    
    
55. VERA-LASTRA O, Ordinola Navarro A, Cruz Dominguez MP, Medina G, et al
    Two cases of Graves' disease following SARS-CoV-2 vaccination: An autoimmune/inflammatory syndrome induced by adjuvants.
    Thyroid. 2021 Apr 15. doi: 10.1089/thy.2021.0142.
    

    >> Share

    
    
56. 
    Correction to: Influence of Dietary Habits on Oxidative Stress Markers in Hashimoto's Thyroiditis by Ruggeri et al. Thyroid 2021;31:96-105. DOI: 10.1089/thy.2020.0299.
    Thyroid. 2021;31:709.
    

    >> Share

    
    
57. VAN REGEMORTER E, Joris V, Van Regemorter V, Marique L, et al
    Downregulation of Caveolin-1 and Upregulation of Deiodinase 3, Associated with Hypoxia-Inducible Factor-1alpha Increase, Are Involved in the Oxidative Stress of Graves' Orbital Adipocytes.
    Thyroid. 2021;31:627-637.
    

    >> Share

    
    December 2020
58. SCAPPATICCIO L, Longo M, Maiorino MI, Pernice V, et al
    Abnormal liver blood tests in patients with hyperthyroidism: systematic review and meta-analysis.
    Thyroid. 2020 Dec 16. doi: 10.1089/thy.2020.0715.
    

    >> Share

    
    November 2020
59. GUO J, Teng D, Shi X, Li Y, et al
    Exposure to the Chinese Great Famine in early life and thyroid function and disorders in adulthood: a cross-sectional study.
    Thyroid. 2020 Nov 2. doi: 10.1089/thy.2020.0325.
    

    >> Share

    
    April 2020
60. AZIZI F
    Long-term treatment of hyperthyroidism with antithyroid drugs: 35 years of personal clinical experience.
    Thyroid. 2020 Apr 7. doi: 10.1089/thy.2019.0814.
    

    >> Share

    
    
61. POZDEYEV N, Erickson T, Zhang L, Ellison K, et al
    Comprehensive Immune Profiling of Medullary Thyroid Cancer.
    Thyroid. 2020 Apr 3. doi: 10.1089/thy.2019.0604.
    

    >> Share

    
    March 2020
62. TAKYAR M, Rahmani M, Amouzegar A, Madreseh E, et al
    Parity and incidence of thyroid autoimmunity a population-based study Tehran thyroid study (TTS).
    Thyroid. 2020 Mar 11. doi: 10.1089/thy.2019.0440.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share